Properties, production, and applications of camelid single-domain antibody fragments

por Harmsen, M. M., De Haard, H. J.
Publicado 2007

PB2305: EFGARTIGIMOD: CLINICAL DEVELOPMENT OF A NOVEL FCRN ANTAGONIST IN THE TREATMENT OF AUTOIMMUNE DISEASES

por Knoebl, P., de Haard, H., Parys, W., Ulrichts, P., Rocca, F., Guglietta, A., Ayguasanosa, J.
Publicado 2022

P19-12. Multimers of llama heavy chain variable domains that bind to the 2F5/4E10 epitope neutralize HIV-1

por Liu, Y, Khatttabi, ME, Forsman, A, Asaa-Chapman, MM, Weiss, RA, Langedijk, H, Hinz, A, Weissenhorn, W, de Haard, H, Verrips, T
Publicado 2009

Broad and potent neutralization of HIV-1 by human-llama fusion antibodies derived from immunized llamas

por McCoy, LE, Rutten, L, Dekkers, G, Blanchetot, C, Strokappe, NM, Forsman-Quigley, A, Seaman, MS, de Haard, H, Verrips, T, Weiss, RA
Publicado 2012